MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Veriheal

AUGUST 31, 2022

Harocopos and his team explain that OPCs, also known as supervised/safe consumption sites, are considered to be “health care facilities that aim to improve individual and community health, increase public safety and reduce the consequences of drug use, including overdose deaths, public drug use and syringe litter.” The Research Letter.

Consumption 104

Consumption Data Treatment Collective 104

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” The bill allocates $2 million for the grant program.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

SEPTEMBER 23, 2021

This Was the World’s First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction. BIMA was an Open-label safety, tolerability and proof-of-concept study to investigate the role of MDMA-Assisted Psychotherapy in treating patients with alcohol use disorder (AUD). Treatment of AUD rates are low at 16%.

Research and Development 52

Research and Development Therapy Treatment Data 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

OCTOBER 22, 2021

To date, more than 50 novel compounds have been evaluated through collaborations with experienced contract research organizations for pharmacokinetic/pharmacodynamic profile, metabolic stability, receptor binding, and safety in order to identify preferred candidates for further development.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. Dr. Tucker has successfully advanced several programs through clinical development and regulatory approval. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

SEPTEMBER 29, 2021

Medical students who register for the program will have access to eight hours of medical cannabis education, including the latest scientific research on the endocannabinoid system and the known effects of cannabis on the human body. About The Cannabinoid Institute ??

Cannabinoids 52

Cannabinoids Education Patients Safety 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 12, 2021

The Parker Psychedelic Research Chair is being funded by Calgary businessman Jim Parker, who donated $3 million to the Hotchkiss Brain Institute to establish the program. She says the treatment did little but left her feeling numb and unable to heal. The treatments were carefully dosed and conducted under medical supervision.

Therapy 105

Therapy Treatment Medicine Sleep 105

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans.

THC 105

THC Pets Events Hemp 105

Illinois News Joint

APRIL 2, 2023

The moneys shall be used to fund crime prevention programs, training, and interdiction efforts, including detection, enforcement, and prevention efforts, relating to the illegal cannabis market and driving under the influence of cannabis. (C) Expenditures for these purposes shall be subject to appropriations. (B)

Education 84

Education Cannabis Collective Programs 84

The Blunt Truth

MAY 26, 2020

Hemp Production Remains Relatively Unscathed, Supported by Demand and Federal Programs. 3] Hemp growers, like other farmers, are further supported by federal programs. 3] Hemp growers, like other farmers, are further supported by federal programs.

CBD 103

CBD Hemp Programs Food 103

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JANUARY 13, 2020

In particular, we see significant market opportunity for nabiximols in several indications in the US and will be progressing multiple late stage clinical programs in 2020.”. Nabiximols (known as “Sativex” outside US) in the US: Commence pivotal clinical program in initial target indication of spasticity associated with Multiple Sclerosis.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 25, 2019

She added, “Here, we are faced with the challenge of balancing public safety concerns like robberies, which the use of body cameras are intended to deter, with individual privacy.”. Social Consumption Pilot Program. We depend on a good relationship with law enforcement. The next regulatory revision process is expected to occur in 2020.

Marijuana 40

Marijuana Safety Programs Retail 40

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives.

Marijuana 103

Marijuana Education Advocacy Legislation 103

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 9] Rachel Nuwer, A Psychedelic Drug Passes a Big Test for PTSD Treatment , N.Y. Defining Psychedelics. 20, 2020), [link]. [8]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Entrepreneurs and businesses leverage this data to navigate the competitive landscape, ensuring they meet market demands.

Marijuana 52

Marijuana Dispensary Supply Chain Research and Development 52

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. Sesen Bio is currently in the follow-up stage of a Phase 3 registration trial in the US for the treatment of BCG-unresponsive NMIBC. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JUNE 15, 2021

In addition to eliminating criminal penalties for drug possession at the federal level, the bill also incentivizes state and local governments to adopt decriminalization policies by otherwise limiting their eligibility to receive funds in the Byrne and COPS grant programs. Promotes evidence-based drug education.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Canna Law Blog

NOVEMBER 26, 2019

The Hemp Rules (WAC 16-306-100) establish a hemp food certification program where hemp producers can voluntarily certify hemp grown for human consumption. In order to participate in the certification program, the producer must inform the WSDA of their desire to participate in the program and also must reimburse the WSDA the costs of testing.

Hemp 89

Hemp Food Compliance Compliance 89

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. Because of these restrictive laws, the federal government enforces harsh rules that make it impossible for researchers to investigate the pros, cons, and safety of cannabis products. . territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Freedom Leaf

OCTOBER 15, 2018

Frontier Data predicts total sales of all CBD products in the U.S. On July 23, the World Health Organization’s Expert Committee on Drug Dependence stated that “no public health problems have been associated with CBD use” and that “CBD has been found to be generally well tolerated with a good safety profile.” will top $1.9 John’s wort.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Ability to provide appropriate research data. By: Kristin Jordan , Senior Counsel.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Ability to provide appropriate research data. Kristin Jordan. Criterion 2. Criterion 5.

Law 40

Law Marijuana Education Cultivation 40